logo-loader
Challenger Acquisitions Limited

Challenger Acquisitions bullish on New York Wheel prospects

Challenger said it was continuing to seek out, evaluate and review another potentially major project

1538060403_New_York_Wheel.png
Challenger has a US$3mln investment in New York Wheel Investors LLC

Challenger Acquisitions Limited (LON:CHAL) said it still believes that the developers of the New York Wheel are motivated to complete the project and that it is waiting for funding arrangements and a new contractor for the project to be finalised.

The leisure-and-entertainment-focused company has a US$3mln investment in New York Wheel Investors LLC, which operates the 192-metre tall wheel being built on the New York Harbour.

READ: Challenger Acquisitions expects investments in giant observation wheel projects to pay off

The wheel is expected to become a major tourist attraction, providing views across the Big Apple.

Construction of the NYW has been postponed since the dismissal of contractor, Mammoet-Starneth, in July last year but the operator has been taking steps to get the project rolling again.

“Looking forward we expect an update from the developers of the New York Wheel Project and we are continuing to seek out, evaluate and review a potential project that can utilise the public company platform in a manner that makes sense from a financial and regulatory perspective,” CEO Mark Gustafson said in a statement on Thursday.

The company said it had raised £400,000 of funding through the issue of new unsecured convertible notes during the first six months of 2018, which has enabled the company to continue operating this year.

Challenger reported a loss of £298,000 in the first six months of the year – down from a loss of £560,000 in the same period a year ago. It said the result was driven primarily by regulatory and financing costs.

Quick facts: Challenger Acquisitions Limited

Price: £0.00

Market: LSE
Market Cap: £403.5 k
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Open Orphan PLC targeting 'value creation and rapid scale-up'

Proactive Research analyst Emma Ulker discusses the opportunity with Open Orphan PLC (LON:ORPH). She says the firm's targeting value creation and rapid scale-up via acquisitions in the orphan and rare drugs market - a space which is growing at around 11% a year. Ulker adds they're looking...

18 hours, 55 minutes ago

2 min read